Latest Operating Expenses News

Zelira Therapeutics has enhanced its financial flexibility through a $1.15 million R&D tax refund and a $1 million At-the-Market equity facility, while progressing FDA trial preparations for its HOPE® 1 autism treatment.

Aeris Environmental Ltd posted solid March quarter results, driven by its AerisTech joint venture’s initial hardware and software sales and expanding consumables segment. The company is leveraging new sustainability regulations to position its smart building ecosystem for growth.

4DMedical Limited reports a 103% surge in year-to-date revenue, secures major contracts with leading healthcare providers, and advances its CT:VQ™ technology towards FDA clearance.

Uscom Limited reported a 14% rise in Q3 customer receipts to $0.73 million, even as cash reserves dropped 38% to $1.34 million, reflecting increased operating costs and global market pressures.

LTR Pharma reports strong Q1 2025 progress with FDA pre-IND meeting success, scientific acclaim for SPONTAN’s rapid absorption, and strategic launch of ROXUS to fast-track US market entry.

Beforepay Group Limited has reported its strongest Q3 FY25 performance yet, with net profit before tax tripling year-on-year and advances growing 16%. The fintech’s strategic expansion of Carrington Labs and funding optimisations signal robust momentum ahead.

Aeeris Ltd delivered solid Q3 FY2025 results, driven by strong recurring revenue growth, a successful new product launch, and strategic moves to internalise key forecasting capabilities.

Mach7 Technologies reported a robust Q3 FY25 with a CARR of A$30.8 million and positive operating cash flow, while announcing a leadership change and reaffirming growth guidance.

BSA Limited reported a robust Q3 FY2025 with revenue and EBITDA growth, but faces significant contract reductions and plans a major restructure to adapt its business model.

Change Financial Limited delivered a record Q3 FY25 revenue of US$3.9 million, driven by strong growth in its Payments as a Service platform and recurring revenue streams, while substantially completing its US operations exit. The company is confident of surpassing 30% revenue growth and achieving its first underlying EBITDA positive result for FY25.

National Australia Bank’s first quarter update reveals a modest 2% dip in cash earnings despite a 3% revenue increase, as credit impairment charges and expenses rise. The bank’s refreshed strategy and strong capital position set the stage for cautious optimism.

MyState Limited reported a modest revenue increase but an 8.9% decline in statutory profit for the half year ended December 2024, while declaring a fully franked interim dividend. The company is set to complete a transformative merger with Auswide Bank, aiming for earnings accretion from FY26.